TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trial.

PLoS One · 2014 · PMC3933342 · PMID 24586226

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Dermatology Life Quality Index (DLQI) showed a trend toward an improvement, the mean score was 2.1 at baseline (range 0–7) and decreased to 1.0 (range 0–3) after cycle 3.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.